期刊
JOURNAL OF PERIODONTOLOGY
卷 91, 期 -, 页码 S19-S25出版社
WILEY
DOI: 10.1002/JPER.20-0088
关键词
inflammation; lipoxin; microbial dysbiosis; periodontal disease; pharmacology; resolvin
资金
- USPHS Grant from the National Institute of Dental and Craniofacial Research [DE025020]
- NIDCR
An initial shift in our understanding of the basis of periodontal disease occurred early in the 2000s. The host response, rather than the bacterial burden, was the principal determinant of the disease. Microbial dysbiosis that occurs in periodontal disease results from a hyperinflammatory state in the host. A second shift in periodontal disease is taking place. This time in the realm of treatment strategies. Rather than targeting antimicrobials or inhibitors of individual inflammatory mediators, preclinical studies support using resolution pharmacology to convert the pro-inflammatory condition into a non-inflammatory one, thereby resolving both the local and systemic inflammation associated with periodontal disease. Here, I describe the bases for these shifts in paradigms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据